CN106858595A - One kind burn tailored version clinical nutrition formula and preparation method thereof - Google Patents
One kind burn tailored version clinical nutrition formula and preparation method thereof Download PDFInfo
- Publication number
- CN106858595A CN106858595A CN201710197736.6A CN201710197736A CN106858595A CN 106858595 A CN106858595 A CN 106858595A CN 201710197736 A CN201710197736 A CN 201710197736A CN 106858595 A CN106858595 A CN 106858595A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- powder
- drinking
- burn
- integration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 49
- 230000035764 nutrition Effects 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 238000009472 formulation Methods 0.000 title abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 90
- 229940088594 vitamin Drugs 0.000 claims abstract description 54
- 229930003231 vitamin Natural products 0.000 claims abstract description 54
- 235000013343 vitamin Nutrition 0.000 claims abstract description 54
- 239000011782 vitamin Substances 0.000 claims abstract description 54
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 54
- 239000000203 mixture Substances 0.000 claims abstract description 45
- 230000035622 drinking Effects 0.000 claims abstract description 31
- 235000008216 herbs Nutrition 0.000 claims abstract description 31
- 230000010354 integration Effects 0.000 claims abstract description 31
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 28
- 235000013305 food Nutrition 0.000 claims abstract description 26
- 235000015097 nutrients Nutrition 0.000 claims abstract description 26
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 22
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 22
- 150000001413 amino acids Chemical class 0.000 claims abstract description 20
- 235000012054 meals Nutrition 0.000 claims abstract description 20
- 241000196324 Embryophyta Species 0.000 claims abstract description 19
- 150000001875 compounds Chemical class 0.000 claims abstract description 19
- 239000002773 nucleotide Substances 0.000 claims abstract description 17
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 17
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000011573 trace mineral Substances 0.000 claims abstract description 16
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 16
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 14
- 235000006264 Asimina triloba Nutrition 0.000 claims abstract description 13
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 13
- 244000189799 Asimina triloba Species 0.000 claims abstract description 12
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 11
- 244000197580 Poria cocos Species 0.000 claims abstract description 11
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 11
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 10
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 9
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 9
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 9
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 9
- 229960003080 taurine Drugs 0.000 claims abstract description 8
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 6
- 239000003925 fat Substances 0.000 claims abstract description 6
- 238000001694 spray drying Methods 0.000 claims abstract description 4
- 238000003809 water extraction Methods 0.000 claims abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 claims abstract 3
- 235000019197 fats Nutrition 0.000 claims description 33
- 235000018102 proteins Nutrition 0.000 claims description 21
- 239000002253 acid Substances 0.000 claims description 19
- 235000001014 amino acid Nutrition 0.000 claims description 18
- 125000001931 aliphatic group Chemical group 0.000 claims description 15
- 239000000839 emulsion Substances 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 15
- 235000000346 sugar Nutrition 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 235000014633 carbohydrates Nutrition 0.000 claims description 13
- 239000000835 fiber Substances 0.000 claims description 9
- 241000206575 Chondrus crispus Species 0.000 claims description 8
- 235000010489 acacia gum Nutrition 0.000 claims description 8
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 235000013373 food additive Nutrition 0.000 claims description 6
- 239000002778 food additive Substances 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 229920001285 xanthan gum Polymers 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 229920001817 Agar Polymers 0.000 claims description 4
- 108010011485 Aspartame Proteins 0.000 claims description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 4
- 229920002752 Konjac Polymers 0.000 claims description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 4
- 229930064664 L-arginine Natural products 0.000 claims description 4
- 235000014852 L-arginine Nutrition 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- 235000010419 agar Nutrition 0.000 claims description 4
- 239000000605 aspartame Substances 0.000 claims description 4
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 4
- 235000010357 aspartame Nutrition 0.000 claims description 4
- 229960003438 aspartame Drugs 0.000 claims description 4
- 235000003132 food thickener Nutrition 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 235000013599 spices Nutrition 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 3
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 3
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 3
- 229920002581 Glucomannan Polymers 0.000 claims description 3
- 229920002907 Guar gum Polymers 0.000 claims description 3
- 229920000161 Locust bean gum Polymers 0.000 claims description 3
- 229940046240 glucomannan Drugs 0.000 claims description 3
- 239000000665 guar gum Substances 0.000 claims description 3
- 235000010417 guar gum Nutrition 0.000 claims description 3
- 229960002154 guar gum Drugs 0.000 claims description 3
- 239000000252 konjac Substances 0.000 claims description 3
- 235000010485 konjac Nutrition 0.000 claims description 3
- 235000010420 locust bean gum Nutrition 0.000 claims description 3
- 239000000711 locust bean gum Substances 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 2
- 238000012163 sequencing technique Methods 0.000 claims description 2
- 239000011805 ball Substances 0.000 claims 1
- 239000002777 nucleoside Substances 0.000 claims 1
- 125000003835 nucleoside group Chemical group 0.000 claims 1
- 230000036039 immunity Effects 0.000 abstract description 9
- 230000002924 anti-infective effect Effects 0.000 abstract description 8
- 230000008859 change Effects 0.000 abstract description 5
- 230000002159 abnormal effect Effects 0.000 abstract description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 3
- 239000004475 Arginine Substances 0.000 abstract description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract description 2
- 230000001575 pathological effect Effects 0.000 abstract description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- 235000013350 formula milk Nutrition 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- -1 lard Substances 0.000 description 13
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 229920002774 Maltodextrin Polymers 0.000 description 9
- 239000005913 Maltodextrin Substances 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 9
- 230000003110 anti-inflammatory effect Effects 0.000 description 9
- 229940035034 maltodextrin Drugs 0.000 description 9
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 235000010469 Glycine max Nutrition 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 8
- 241000245665 Taraxacum Species 0.000 description 8
- 239000005862 Whey Substances 0.000 description 8
- 108010046377 Whey Proteins Proteins 0.000 description 8
- 102000007544 Whey Proteins Human genes 0.000 description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 8
- 230000029663 wound healing Effects 0.000 description 8
- 244000068988 Glycine max Species 0.000 description 7
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 241000251468 Actinopterygii Species 0.000 description 6
- 108010073771 Soybean Proteins Proteins 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 235000019688 fish Nutrition 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 231100000668 minimum lethal dose Toxicity 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 239000011435 rock Substances 0.000 description 6
- 235000019710 soybean protein Nutrition 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229920001202 Inulin Polymers 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 108010038807 Oligopeptides Proteins 0.000 description 5
- 102000015636 Oligopeptides Human genes 0.000 description 5
- 235000004347 Perilla Nutrition 0.000 description 5
- 244000124853 Perilla frutescens Species 0.000 description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 5
- 244000046052 Phaseolus vulgaris Species 0.000 description 5
- 235000011453 Vigna umbellata Nutrition 0.000 description 5
- 240000001417 Vigna umbellata Species 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 239000003240 coconut oil Substances 0.000 description 5
- 235000019864 coconut oil Nutrition 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 239000004519 grease Substances 0.000 description 5
- 230000002949 hemolytic effect Effects 0.000 description 5
- 230000036737 immune function Effects 0.000 description 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 5
- 229940029339 inulin Drugs 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 239000004006 olive oil Substances 0.000 description 5
- 235000008390 olive oil Nutrition 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 235000015424 sodium Nutrition 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000003549 soybean oil Substances 0.000 description 5
- 235000012424 soybean oil Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 102000004895 Lipoproteins Human genes 0.000 description 4
- 108090001030 Lipoproteins Proteins 0.000 description 4
- 240000003183 Manihot esculenta Species 0.000 description 4
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 235000013734 beta-carotene Nutrition 0.000 description 4
- 239000011648 beta-carotene Substances 0.000 description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 4
- 229960002747 betacarotene Drugs 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 235000021277 colostrum Nutrition 0.000 description 4
- 210000003022 colostrum Anatomy 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 239000011162 core material Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229960000304 folic acid Drugs 0.000 description 4
- 235000019152 folic acid Nutrition 0.000 description 4
- 239000011724 folic acid Substances 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 229940055726 pantothenic acid Drugs 0.000 description 4
- 235000019161 pantothenic acid Nutrition 0.000 description 4
- 239000011713 pantothenic acid Substances 0.000 description 4
- 235000019477 peppermint oil Nutrition 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 239000011691 vitamin B1 Substances 0.000 description 4
- 239000011715 vitamin B12 Substances 0.000 description 4
- 239000011716 vitamin B2 Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 239000011647 vitamin D3 Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 235000008939 whole milk Nutrition 0.000 description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 229940091250 magnesium supplement Drugs 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 206010058041 Wound sepsis Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000001989 choleretic effect Effects 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 231100000132 chronic toxicity testing Toxicity 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010004053 Bacterial toxaemia Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 206010051548 Burn infection Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102100035695 Gamma-aminobutyric acid receptor-associated protein Human genes 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000175212 Herpesvirales Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 101001001372 Homo sapiens Gamma-aminobutyric acid receptor-associated protein Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 240000001740 Momordica dioica Species 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- 244000179886 Moringa oleifera Species 0.000 description 1
- 235000011347 Moringa oleifera Nutrition 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 102000015094 Paraproteins Human genes 0.000 description 1
- 108010064255 Paraproteins Proteins 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001300674 Plukenetia volubilis Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000287420 Pyrus x nivalis Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 241000235546 Rhizopus stolonifer Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010061372 Streptococcal infection Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000020243 first infant milk formula Nutrition 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000007358 intestinal barrier function Effects 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical group [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000009854 mucosal lesion Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000007949 saponins Chemical group 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to one kind burn tailored version clinical nutrition formula, including protein and amino acid, nucleotides, fat, carbohydrate, dietary fiber, macroelement, trace element, vitamin, meals elite, integration of drinking and medicinal herbs composition, natural plants compound and new resource food;Wherein amino acid includes L glutamine, L arginine, taurine;Integration of drinking and medicinal herbs composition includes peppermint, Poria cocos, pawpaw, dandelion, spina date seed, honeysuckle;Its preparation method is:Each component is made powder in advance, is then made corresponding formulation, and wherein integration of drinking and medicinal herbs composition carries out water extraction concentration, spray drying and is made powder, and vitamin and fat are processed by microencapsulation and is made powder;Or by wet processing each component is carried out emulsifying homogeneous, spray drying be made powder.Compared with prior art, nutrient formulation of the present invention can correct the abnormal pathologic of fire victim, physiological change, strengthen the immunity and anti-infection ability of patient, and the normal function of body is maintained comprehensively.
Description
Technical field
The present invention relates to enteral nutrition preparation field, and in particular to one kind burn tailored version clinical nutrition formula and its preparation
Method.
Background technology
Burn is the infringement that heating power causes skin or other tissues, refers mainly to skin or mucous membrane, and severe patient can also injure skin
Lower or sub-mucosal tissues, such as muscle, bone, joint even internal organ.Area is big, the serious burn more than depth, can cause the whole body one to be
The physiologic derangement of row, such as nerve, endocrine, breathing, excretory system;The function of each main organs and metabolism and immune response are all
Change, burn is a kind of wound of systemic damage, in CC, it may occur however that infection, toxaemia septicemia and
Other severe complications.
Burnt degree patient due to tissue serious damage, and by violent stress reaction and the shadow of various neuroendocrine factors
Ring, body all occurs a series of changes in terms of sugar, protein, fat, vitamin, metabolism of trace elements.On the one hand tissue divides
Solution aggravation, protein is largely lost, and energy ezpenditure increases, and metabolic rate is raised;When another aspect body recovery and wound repair
Need a large number of nutrients.Correct metabolic nutrition support and conditioning, advantageously reduce organism metabolism consumption, safeguard organ function,
Enhancing immunologic mechanism, prevention and infection control, wound healing.
But the treatment means currently for fire victim are generally wound external application painting medicament, oral traditional Chinese medicine preparation, parenteral battalion
Support agent (as being injected intravenously).Wound external application applies medicament and oral traditional Chinese medicine preparation is only used for the anti-inflammatory analgetic of wound, eliminates infection, promotees
Enter wound healing, it can not provide the comprehensively nutritional need such as protein, fat for fire victim;Parenteral nutrition agent is (such as quiet
Arteries and veins is injected) although certain nutritional support can be provided for fire victim, transfusion capacity and nutriment input quantity are difficult to control to,
And transfusion time is more long.
With the development of food of special nutrients, according to the physilogical characteristics and nutritional need of fire victim, for fire victim
The special formulation food of exploitation is also increasing, and for example Chinese patent CN105901703A discloses a kind of for fire victim's
Marine organism type enteral nutrition preparation, it contains following active ingredient:Protein, fat, carbohydrate, B B-complex,
Composite mineral matter, Taurine, choline etc., it can provide balanced nutritious for patient, but not refer to the anti-infective energy of fire victim
Power, and its active ingredient and be not added with integration of drinking and medicinal herbs composition and natural plants compound, its nutritional need to fire victim and
Recovery time exists certain not enough.
Therefore, developing the various nutrients needed for can providing fire victim, and can improve the immunity, anti-infective burnt
Ability, and then the enteral nutritional prescription product of therapeutic effect is improved, with important value and wide market.
The content of the invention
It is an object of the invention to overcome defect of the prior art, there is provided one kind burn tailored version clinical nutrition formula and
Its preparation method, burn tailored version clinical nutrition formula comprehensive nutritional support for fire victim provides prepared by the present invention, its
Suitable energy and various critical nutrients needed for containing fire victim, there is provided completely must micro-nutrient composition;Pass through
Integration of drinking and medicinal herbs composition of the addition containing various functional active components, regulation body function improves resistance, improves anti-infection ability,
Coordinating intestines and stomach, promotes the absorption of all kinds of nutriments simultaneously, and each composition complements each other in nutrient formulation of the present invention, can have
The nutrition intake that effect improves fire victim is not enough, and conditioning engine body function, is conducive to the early recovery of fire victim.
To achieve the above object, the present invention is adopted the following technical scheme that:
On the one hand, the present invention provides a kind of burn tailored version clinical nutrition formula, including following component:Protein and amino
Acid, nucleotides, fat, carbohydrate, dietary fiber, macroelement, trace element, vitamin, meals elite, integration of drinking and medicinal herbs
Composition, natural plants compound and new resource food;Wherein, the amino acid includes Glu, L-arginine, ox sulphur
Acid;Wherein, the integration of drinking and medicinal herbs composition includes peppermint, Poria cocos, pawpaw, dandelion, spina date seed, honeysuckle.
In order to further optimize above-mentioned technical proposal, the technical measures that the present invention is taken also include:
Preferably, the ratio of n-6 aliphatic acid and n-3 aliphatic acid is 4 in the fat:1~2.
Preferably, the burn tailored version clinical nutrition formula, also including food thickening agent and food additives, the food
Product thickener be guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, Arabic gum at least
One kind, the food additives are at least one in Aspartame, flavoring essence spices, brown sugar.
Preferably, the vitamin is water soluble vitamin and liposoluble vitamin, the weight of the liposoluble vitamin
Account for the 10%~40% of vitamin gross weight.
Preferably, the dietary fiber is water-soluble dietary fiber.
Preferably, the parts by weight of the component are:Protein and 20~40 parts of amino acid, 0~1 part of nucleotides, fat
10~20 parts, 30~60 parts of carbohydrate, 2~8 parts of dietary fiber, 0.6~1.2 part of macroelement, trace element 0.05-
0.2 part, 0.1~0.3 part of vitamin, 0.2~0.5 part of meals elite, 0.2~3 part of integration of drinking and medicinal herbs composition, natural plants compound
0.1-1 parts and new resource food 0.01-0.2 parts.
Preferably, the parts by weight of each component are as follows in the integration of drinking and medicinal herbs composition:0~1 part of peppermint, 0~1 part of Poria cocos,
0~1 part of pawpaw, 0~1 part of dandelion, 0~1 part of spina date seed, 0~1 part of honeysuckle.
Preferably, the protein is selected from PURE WHEY, soybean protein isolate, whole milk powder, dried whole-egg, newborn iron egg
In vain, at least one in bovine colostrum, protein peptides;Wherein, the protein peptides are selected from soybean oligopeptide, wheat protein peptide, silkworm chrysalis
At least one in protein peptides, ocean fish oligopeptide powder, laughable peptide, amino peptide, ovalbumin peptide
Preferably, the amino acid is selected from 1B-Pidolidone, Pidolidone, L-arginine, L-Trp, L-
At least one in glutamine, taurine, Valine, ILE, L-Leu.
Preferably, the nucleotides is 5'- monophosphate cytidines.
Preferably, the fat includes saturated fatty acid, polyunsaturated fatty acid, monounsaturated fatty acids, OPO structures
At least one in fat, DHA, EPA, ARA, phosphatide, more specifically it is described fat include safflower seed oil, walnut oil, peanut oil,
Soybean oil, Ah's glycerine, olive oil, tea oil, oil and fat of sacha inchi, coconut oil, perilla herb oil, deep sea fish oil, cupu oil, palm oil, butter,
Cream, lard, medium chain triglyceride, lecithin, single diglycerine fatty acid ester.
Preferably, the carbohydrate is including in fructose, rock sugar, lactose, maltodextrin, tapioca, resistant starch
At least two.
Preferably, the dietary fiber comprising inulin, konjaku flour, galactooligosaccharide, FOS, oligoisomaltose,
At least one in soybean polyoses, cyclodextrin, resistant dextrin, fibre and soya.
Preferably, the macroelement is selected from calcium citrate, L-calcium lactate, calcium monohydrogen phosphate, K-IAO, citric acid
At least one in sodium, magnesium gluconate, magnesium sulfate.
Preferably, the trace element is selected from ferrous gluconate, KI, zinc gluconate, sodium selenite, glucose
At least one in sour copper, chromium sulfate, manganese gluconate and sodium molybdate.
Preferably, the liposoluble vitamin is selected from vitamin A, beta carotene, vitamin D3, vitamin E, vitamin K1
In at least one.
Preferably, the water soluble vitamin is selected from vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin
At least one in C, pantothenic acid, folic acid, nicotinic acid, choline, inositol, biotin.
Preferably, the meals elite is selected from cereal, beans, potato class, greengrocery, Homonemeae, nut-seed class, fishes and shrimps
At least one in class, poultry meat, fruits;Wherein described cereal it is main by rice meal, millet powder, black rice flour, coixlacrymajobi powder,
One kind in corn flour, wheat germ powder, oatmeal, buckwheat or at least two compositions, the beans it is main by peameal, it is green
One kind or at least two compositions in bean powder, black bean powder, red bean powder, soy meal, the potato class are mainly made up of common yam rhizome powder, described
Vegetable powder is main by carrot meal, white radish powder, pumpkin powder, spinach powder, tomato meal, broccoli powder, balsam pear powder, cucumber powder
Plant or several compositions, the Homonemeae is main by one or more in mushroom powder and white fungus powder, and the nut-seed class is main
It is lotus nut starch, the fish and shrimp are mainly and are made up of one or more in salmon powder and cod meal, the poultry meat master
If being made up of one or more in chicken meal, powdered beef, the fruits are main by red date powder, longan powder, apple powder, cherry
One or more compositions in peach powder, oranges and tangerines powder, pyrus nivalis powder;The preferred red bean powder of meals elite.
Preferably, the natural plants compound is selected from l-cn, Glucosamine, FOS, lutein, tomato
At least one in red pigment, resveratrol, allicin;The natural plants compound is preferably l-cn.
Preferably, the new resource food is selected from first milk basic protein, GABA, chitosan oligosaccharide, eucommia Bark male flower, freshwater mussel
Meat polysaccharide, phytosterol, bamboo-leaves flavones, CPP, avenabeta glucosan, yeast beta-dextran, leaf of Moringa, oligomeric wood
At least one in sugar;The new resource food is preferably phytosterol.
On the other hand, it is the present invention relates to a kind of preparation method of above-mentioned burn tailored version clinical nutrition formula including as follows
Step:
It is step one, the protein and amino acid of predetermined weight number, nucleotides, fat, carbohydrate, meals are fine
Dimension, macroelement, trace element, vitamin, integration of drinking and medicinal herbs composition, natural plants compound and new resource food are prepared respectively
Into the powder that particle diameter is 150~250 μm;
Step 2, the powder for preparing the step one are poured into cone-type mixer and are well mixed successively;
Step 3, using the step one be well mixed powder be prepared into nutrient powder, nutrition emulsion, capsule, tablet,
At least one in pill or oral liquid;
Wherein, the raw material of the integration of drinking and medicinal herbs composition is crushed, water extraction concentrates, and concentrate is carried out into spray drying system
Into integration of drinking and medicinal herbs component powders;
Wherein, the vitamin and fat are processed by microencapsulation be prepared into vitamin powder and fat powder respectively.
Preferably, the preparation process of the integration of drinking and medicinal herbs component powders is as follows:Using pulverizer to predetermined weight number
Raw material is crushed, and the raw material of crushing is placed in container, and it is 3~8 times of raw material weight of water to add weight, carries out immersion 3
~4 hours, 30~60min of decoction is then carried out to soak, filtering removal raw material leaves and takes decoction liquor, decoction liquor is sprayed
Mist drying prepares integration of drinking and medicinal herbs component powders.
Preferably, what the microencapsulation of the vitamin was processed comprises the following steps that:1) using liposoluble vitamin as core
Material, from sodium carboxymethylcellulose, gelatin, carragheen, xanthans, Arabic gum, maltodextrin, lipoprotein, corn syrup, big
Beans separate albumen, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, fibre and soya, lactose, rock sugar
One or more in powder, emulsifying agent, stabilizer as wall material, high-pressure homogeneous emulsification, spraying is instantaneous to be dried, and screening prepares liposoluble
Property vitamin powder;2) using water soluble vitamin as core, from sodium carboxymethylcellulose, gelatin, carragheen, xanthans,
Arabic gum, maltodextrin, lipoprotein, corn syrup, soybean protein isolate, whole-fat milk powder, dietary fiber, inulin, whey egg
Mixed as wall material for one or more in white powder, oligoisomaltose, fibre and soya, lactose, candy sugar powder, emulsifying agent, stabilizer
Close uniform, spraying is instantaneous to be dried, and screening prepares water soluble vitamin powder.
Preferably, the specific implementation step of the micro-capsule embedding techniques of the fat is as follows:By fat, emulsifying agent, wall material with
Water mixed dissolution prepares emulsion;After by the stirring mixing of above-mentioned emulsion, emulsifying homogeneous treatment is carried out, then carry out spraying dry
Dry, screening prepares powdered oil, and powdered oil compares with conventional grease, and its dispersiveness, water solubility, emulsibility, inoxidizability are all
Improve a lot;Wherein, the emulsifying agent be selected from fatty acid glyceride (glyceride), methyl glycol fatty acid ester (propylene glycol ester),
One or more in sorbitan aliphatic ester (sorbitan acid), sucrose fatty ester (sucrose ester), lecithin;The wall
Material is selected from sodium carboxymethylcellulose, gelatin, carragheen, xanthans, Arabic gum, maltodextrin, lipoprotein, corn syrup, big
Beans separate albumen, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, fibre and soya, lactose, rock sugar
One or more in powder, emulsifying agent, stabilizer.
The present invention also provides a kind of preparation method of above-mentioned burn tailored version clinical nutrition formula, and it is wet processing, bag
Include following steps:
Step 1) prepare the protein containing predetermined weight number and amino acid, nucleotides, fat, carbohydrate, meals
The original of food fiber, macroelement, trace element, vitamin, integration of drinking and medicinal herbs composition, natural plants compound and new resource food
Material, according to the physical behavior of raw material, adds successively according to sequencing, is stirred while addition, and raw material is obtained
Mixed emulsion;
Step 2) by step 1) temperature of mixed emulsion that obtains is maintained at 40-50 DEG C, adjustment homogenization pressure makes it all the time
Be maintained between 10-18Mpa, emulsifying homogeneous carried out to mixed emulsion, then by emulsion place evaporator in, with default skill
Art parameter is concentrated, and sterilization is carried out at 85-88 DEG C, obtains concentrate;
Step 3) by step 2) concentrate that obtains is spray-dried, and crosses 60~80 mesh sieves, is prepared into powder;Using upper
State at least one during powder is prepared into nutrient powder, nutrition emulsion, capsule, tablet, pill or oral liquid.
Using having strengthen immunity, improving anti-infective, function of spleen and stomach regulating integration of drinking and medicinal herbs composition, it includes thin the present invention
Lotus, Poria cocos, pawpaw, dandelion, spina date seed, honeysuckle.
Active ingredient peppermint oil, menthol in peppermint can suppress the life of the fungies such as sclerotinite, rhizopus stolonifer, mucor
Long and breeding;Peppermint oil shows stronger inhibitory action to two kinds of hypotypes (HSV21 and HSV22) of herpes simplex virus;Together
When peppermint oil have obvious choleretic effect, and can slightly increase the discharge rate of bile acid in bile;And peppermint oil Carrageenan
Causing rat paw edema has certain inhibitory action, has functions that anti-inflammatory analgesic.
Poria cocos can strengthen body's immunity, and it has the effect of anti-atrophy of thymus gland, the increase of anti-spleen and tumor suppression growth;Fu
Siberian cocklebur polysaccharide has obvious antitumor action;There are diuresis, the discharge of the electrolyte such as potassium, sodium, chlorine in urinating can be increased;Have it is calm and
The effects such as protection liver, generation, the hypoglycemic, anti-radiation for suppressing ulcer;Poria cocos also has antibacterial, anti-inflammatory, antivirus action, its
There is inhibitory action to staphylococcus aureus, staphylococcus albus, A type/beta streptococcus etc..
Contain multiple beneficial composition, including pawpaw polysaccharide, papain, oleanolic acid, phytosterin compound in pawpaw
Deng;Pawpaw polysaccharide has anticoagulation, suppression infection, imperial radiation, antitumor, anti-inflammatory, antiviral, the anti-ageing effect of waiting for a long time, and is preferable
Immunopotentiator;Papain can decomposing protein, have auxiliary treatment enterogastritis, indigestion, pawpaw contains various water
Soluble vitamin, is such as rich in vitamin C, helps to repair body tissue, eliminates the noxious material of infringement body cell, strengthens people
Body resistance against diseases;Oleanolic acid exists with monomer or saponin form, internal with anti-inflammatory, strengthen immunity, transaminase lowering, correction
Paraprotein is metabolized, prevents cirrhosis;Phytosterin compound, has stronger antiinflammatory action to human body, can promote wound healing,
Make hypertrophy, enhancing capillary circulation.
There is dandelion resisting pathogenic microbes to act on, and it has to staphylococcus aureus resistance bacterial strain, hemolytic streptococcus
Stronger bactericidal action, to Diplococcus pneumopniae, meningococcus, corynebacterium diphtheriae, Pseudomonas aeruginosa, proteus, shigella dysenteriae, wound
Cold bacillus etc. and micrococcus catarrhalis also have certain bactericidal action;With liver protection, choleretic effect, the paddy third that it causes to carbon tetrachloride
Transaminase is raised obvious inhibiting effect, can significantly alleviate the Histological change that carbon tetrachloride hepatic injury causes;With anti-stomach
Ulcer function, it has notable protective effect to mucosal lesion;With the effect for improving immunologic function, human peripheral pouring can be improved
Bar cell blasts conversion ratio, Taraxacum Polysaccharides can significantly increase ehrlich carcinoma and MM46 tumor-cell antigen induced mice foots pad are slow
Hair style hypersensitivity intensity.
Active ingredient soaping agents and flavone compound in spina date seed have significant calm and syngignoscism, spina date seed
Also there is obvious anticonvulsant action, can substantially suppress excitation of the Benzylpenicillin sodium salt to neuronal cell, reduce glutamic acid water
Flat rising, and have antiepileptic action;Spina date seed glycoside also shows have significant protective effect to cardiovascular system, with anti-
Scheming ischemic effect;Spina date seed aqueous extract has obvious antiinflammatory action, can suppress mouse peritoneal, skin of back and auricle hair
Thin vasopermeability, has inhibitory action to the granuloma that the swelling of rat hindleg egg white and the rat oxter implantation scraps of paper are produced.
Honeysuckle is to the double balls of various pathogens such as staphylococcus aureus, hemolytic streptococcus, pneumococcus, meningitis
Bacterium, Pseudomonas aeruginosa etc. have antibacterial and bactericidal action, and infected by influenza, orphan virus, herpesviral, Leptospira have suppression
Effect;Honeysuckle has clearing heat and detoxicating, dispelling wind and heat from the body effect, can treat summer fever, rush down dysentery, influenza, sore furuncle poison, acute and chronic
The diseases such as tonsillitis, periodontitis.
The present invention is also used includes the amino acid and nucleotides of Glu, L-arginine, taurine.Glutamine
Small intestine epithelium can be repaired, intestinal barrier function is maintained, enteric bacteria and toxin displacement is prevented and reduced enterogenic infection.Arginine
Arginic nutritional support can be strengthened can effectively facilitate cellular immune function, immunity be effectively improved, to inhibiting tumor cell and prevention
Virus infection.Nucleotides can correct the Cellular Immune Disturbances of burn patient, reduce wound sepsis's incidence, mitigate burn
Infection, improves fire victim's immunologic function, and fire victim's immunological function repression is corrected from cellular level, it is rebuild immune work(
Energy.
The ratio that n-6 aliphatic acid and n-3 aliphatic acid in fat are used in the present invention is 4:1~2, n-3 aliphatic acid can adjust
The inflammatory reaction of immunity, improves sepsis or MOF as much as possible.
New resource food phytosterol is used in the present invention, it has stronger antiinflammatory action to human body, with can press down
Human body processed is to the absorption of cholesterol, the katabolism that promotes cholesterol, the effect such as biochemical synthesis that suppresses cholesterol;It can promote
Wound healing, makes the functions such as hypertrophy, enhancing capillary circulation.
Compared with prior art, the present invention has following excellent effect:
(1) with Traditional Chinese medical theory be combined modern nutriology achievement in research by the present invention, by the organic of various components
Combination, various functions are merged, and by the synergy between active ingredient, humidification effect.Match somebody with somebody by the present invention
The food that side makes can not only supplement nutrition needed for fire victim, moreover it is possible to promote body condition improvement using medicinal herb componentses.
(2) present invention addition has integration of drinking and medicinal herbs composition that is anti-infective, strengthening immune conditioning digestion effect, adds raising
Immunity, the amino acid and nucleotides that reduce wound sepsis's incidence, mitigate infection of burn, addition can adjust immunity
The n-3 aliphatic acid of inflammatory reaction, phytosterol of the addition with anti-inflammatory, promotion wound healing, its each component complements each other, treats
Effect is definite, can correct abnormal pathologic, the physiological change of fire victim, maintain body cell and tissue, the normal configuration of organ and
Function, enhancing patient is immune, therapeutic effect is improved, with early recovery.
(3) present invention with the addition of dietary fiber, its nutritional status that can improve Cavity in Critical Patients, and the negative nitrogen for correcting body is put down
Weighing apparatus;Improve the immunologic function of Cavity in Critical Patients, reduce the generation of complication;The blood sugar of Cavity in Critical Patients is effectively reduced, is reduced high
The harm of blood sugar, mitigates the stress reaction of patient;Promote gastrointestinal motility, improve gastrointestinal function, mitigate excessive inflammatory reaction,
Prevent the generation of enterogenic infection.
(4) present invention prepares vitamin using micro-capsule embedding techniques, and vitamin is embedded in wall material, can prevent dimension from giving birth to
Element is destroyed by macroelement, trace element, extends the holding time of vitamin;The present invention is prepared using micro-capsule embedding techniques
Powdered oil so that powdered oil has preferable mobility, it is easy to be well mixed with other powdered components;And use micro-capsule bag
After burying technology, grease is embedded in wall material, so as to avoid the contact with air to strengthen inoxidizability, so as to guarantor can be played
The maximum effect of strong type grease.
(5) raw material of burn tailored version clinical nutrition formula of the present invention in preparation process it is previously prepared into
150~250 μm of powder, this is caused when finished product is prepared, and each nutrition composition can be well mixed, it is ensured that each in unit volume
The content of nutrition composition is identical, while when liquid type preparation is prepared, each nutrition composition can be fully dispersed and be completely dissolved to molten
In agent, prevent solids of sedimentation occur in liquid, effect of finished product product has been effectively ensured.
Specific embodiment
The present invention provides a kind of for burn tailored version clinical nutrition formula tailored version clinical nutrition formula, including following weight
Measure the component of number:20~40 parts of protein and amino acid, 0~1 part of nucleotides, 10~20 parts of fat, carbohydrate 30~
60 parts, 2~8 parts of dietary fiber, 0.6~1.2 part of macroelement, 0.05-0.2 parts of trace element, 0.1~0.3 part of vitamin, meals
0.2~0.5 part of elite of food, 0.2~3 part of integration of drinking and medicinal herbs composition, 0.1-1 parts of natural plants compound and new resource food
0.01-0.2 parts;Wherein, the vitamin is water soluble vitamin and liposoluble vitamin, the weight of the liposoluble vitamin
Account for the 10%~40% of vitamin gross weight;Wherein, the dietary fiber is water-soluble dietary fiber, n-6 fat in the fat
Fat acid is 4 with the ratio of n-3 aliphatic acid:1~2.
With reference to embodiment, specific embodiment of the invention is further described.Following examples are only used for more
Plus the technical solution of the utility model is clearly demonstrated, and can not be limited the scope of the invention with this.
Embodiment 1
Burn tailored version clinical nutrition formula of the present invention includes PURE WHEY 10.4g, soybean protein isolate
5.2g, whole milk powder 12g, dried whole-egg 0.33g, colostrum 0.16g, taurine 0.12g, ocean fish oligopeptide 0.1g;The mono- phosphorus of 5'-
Sour cytidine 0.1g;Olive oil 2.77g, soybean oil 4.48g, coconut oil 2.77g, perilla herb oil 0.64g, medium chain triglyceride 0.21g;
Maltodextrin 35g, rock sugar 6.2g, tapioca 7.49g;Dietary fiber 3.5g;Calcium 0.44g, phosphorus 0.23g, potassium in macroelement
0.08g, sodium 0.14g, magnesium 0.19g;Iron 0.015g, iodine 0.00014g, zinc 0.13g in trace element;Vitamin A 0.0005g,
Beta carotene 0.000057g, vitamin D30.000002g, vitamin E 0.01g;Vitamin B10.001g, vitamin B2
0.001g, vitamin B60.001g, vitamin B120.000003g, vitamin C 0.188g, pantothenic acid 0.005g, folic acid
0.000165g, nicotinic acid 0.0161g;Red bean powder 0.33g;Peppermint 0.05g, Poria cocos 0.05g, pawpaw 0.05g, dandelion 0.05g,
Spina date seed 0.05g, honeysuckle 0.05g;L-cn 0.63g in natural plants compound,;Phytosterol in new resource food
0.05g;Wherein, the dietary fiber is all water-soluble dietary fiber;The weight of the liposoluble vitamin accounts for vitamin gross weight
The 10%~40% of amount;The ratio of n-6 aliphatic acid and n-3 aliphatic acid is 4 in the fat:1.
Embodiment 2
Burn tailored version clinical nutrition formula of the present invention includes PURE WHEY 10.4g, soybean protein isolate
5.2g, whole milk powder 12g, dried whole-egg 0.33g, colostrum 0.16g, taurine 0.12g, ocean fish oligopeptide 0.1g;Olive oil
2.77g, soybean oil 4.48g, coconut oil 2.77g, perilla herb oil 0.64g, medium chain triglyceride 0.21g;Maltodextrin 35g, rock sugar
6.2g, tapioca 7.49g;Dietary fiber 3.5g;Calcium 0.44g, phosphorus 0.23g, potassium 0.08g, sodium 0.14g, magnesium in macroelement
0.19g;Iron 0.015g, iodine 0.00014g, zinc 0.13g in trace element;Vitamin A 0.0005g, beta carotene
0.000057g, vitamin D30.000002g, vitamin E 0.01g;Vitamin B10.001g, vitamin B20.001g, dimension
Raw element B60.001g, vitamin B120.000003g, vitamin C 0.188g, pantothenic acid 0.005g, folic acid 0.000165g, nicotinic acid
0.0161g;Red bean powder 0.33g;Peppermint 0.17g, Poria cocos 0.17g, pawpaw 0.17g, dandelion 0.17g, spina date seed 0.17g, gold
Honeysuckle flower 0.17g;L-cn 0.63g in natural plants compound,;Phytosterol 0.1g in new resource food;Wherein, the meals
Food fiber is all water-soluble dietary fiber;The weight of the liposoluble vitamin accounts for the 10%~40% of vitamin gross weight;Institute
The ratio for stating n-6 aliphatic acid and n-3 aliphatic acid in fat is 4:1.
Embodiment 3
Burn tailored version clinical nutrition formula of the present invention includes PURE WHEY 10.4g, soybean protein isolate
5.2g, whole milk powder 12g, dried whole-egg 0.33g, colostrum 0.16g, taurine 0.12g, ocean fish oligopeptide 0.1g;Olive oil
2.77g, soybean oil 4.48g, coconut oil 2.77g, perilla herb oil 0.64g, medium chain triglyceride 0.21g;Maltodextrin 35g, rock sugar
6.2g, tapioca 7.49g;Dietary fiber 3.5g;Calcium 0.44g, phosphorus 0.23g, potassium 0.08g, sodium 0.14g, magnesium in macroelement
0.19g;Iron 0.015g, iodine 0.00014g, zinc 0.13g in trace element;Vitamin A 0.0005g, beta carotene
0.000057g, vitamin D30.000002g, vitamin E 0.01g;Vitamin B10.001g, vitamin B20.001g, dimension
Raw element B60.001g, vitamin B120.000003g, vitamin C 0.188g, pantothenic acid 0.005g, folic acid 0.000165g, nicotinic acid
0.0161g;Red bean powder 0.33g;Peppermint 0.17g, Poria cocos 0.17g, pawpaw 0.17g, dandelion 0.17g, spina date seed 0.17g, gold
Honeysuckle flower 0.17g;L-cn 0.63g in natural plants compound,;Phytosterol 0.05g in new resource food;Wherein, it is described
Dietary fiber is all water-soluble dietary fiber;The weight of the liposoluble vitamin accounts for the 10%~40% of vitamin gross weight;
The ratio of n-6 aliphatic acid and n-3 aliphatic acid is 4 in the fat:1.
Embodiment 4
The preparation method of the burn tailored version clinical nutrition formula containing embodiment 1- embodiments 3 is as follows:
1) powdered oil (powder fat) is prepared:
A) the wall material aqueous solution is prepared:Take 8 grams of maltodextrin, 4 grams of soybean protein isolate, 11 grams of whole-fat milk powder, dietary fiber 2
Gram (resistant dextrin), 0.5 gram of inulin, 5 grams of PURE WHEY, 0.5 gram of oligoisomaltose, 1 gram of fibre and soya, Arabic gum
0.2 gram, 0.5 gram of lactose, 2 grams of candy sugar powder, 50 milliliters of water stirs and (has ready conditions and heat while stirring to 60 DEG C, kept for 30 points
Room temperature is cooled to after clock).
B) monoglyceride taken 0.1 gram (total solid concentration be 0.2%) is uniform to be dissolved in (olive oil in 10.2 milliliters of greases
2.6 milliliters, 4.2 milliliters of soybean oil, 2.6 milliliters of coconut oil, 0.6 milliliter of perilla herb oil, 0.2 milliliter of medium chain triglyceride).
C) Tween 80 is taken into 0.1 gram (total solid concentration is 0.2%) to be uniformly dissolved in the wall material aqueous solution.
D) the wall material aqueous solution of the mixed plant grease with addition Over emulsfication agent Tween 80 of Over emulsfication agent monoglyceride will be added
It is sufficiently mixed.
E) addition stabilizer agar is taken after 0.1 gram (total solid concentration be 0.2%) enter mixed solution, is settled to water
200 milliliters (total solid concentration is 25%), disperses at a high speed 2 minutes under 20000r/min.
F) homogenization pressure is 25MPa, and homogeneous 3 times (every time 5 minutes) is obtained homogeneous emulsion.
G) obtained emulsion is spray-dried, EAT is 195 DEG C, leaving air temp is 80 DEG C.Collect powder
Grease (powder fat).
2) integration of drinking and medicinal herbs component powders are prepared:The raw material of predetermined weight number is crushed using pulverizer, will be crushed
Raw material be placed in container, it is 3~8 times of raw material weight of water to add weight, immersion is carried out 3~4 hours, then to soak
30~60min of decoction is carried out, filtering removal raw material is left and taken decoction liquor, decoction liquor is spray-dried, with 60~80 mesh sieves point
Prepare integration of drinking and medicinal herbs component powders;
3) vitamin powder is prepared:Using the liposoluble vitamin of predetermined weight number as core, from carragheen, I
Primary glue carries out 2 emulsifying homogeneous treatment under high pressure as wall material, and the emulsifying homogeneous time is 10~15min, is then sprayed
It is instantaneous to dry, prepare liposoluble vitamin powder with 60~80 mesh sieves point;Using the water soluble vitamin of predetermined weight number as
Core, from maltodextrin, lipoprotein as wall material, is well mixed, and spraying is instantaneous to be dried, and is prepared with 60~80 mesh sieves point water-soluble
Property vitamin powder;
4) by the protein and amino acid of predetermined weight, nucleotides, carbohydrate, dietary fiber, macroelement, micro
Element, meals elite, natural plants compound and new resource food are prepared into the powder that particle diameter is 150~250 μm respectively;
5) by step 1)~step 4) obtained by powder sequentially add the mixer of cone-type mixer or other forms and mix
Uniformly prepared formula mixture is closed, it is standby by after sterilization processing;
6) according to conventional technical means by step 5) in formula mixture be prepared into nutrient powder, nutrition emulsion, capsule,
At least one in tablet, pill or oral liquid.
In step 6) in, optionally increase appropriate food thickening agent and food additives.The food thickening agent
It is at least one in guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, Arabic gum, it is described
Food additives are at least one in Aspartame, flavoring essence spices, brown sugar;More preferably carragheen, Arabic gum, Guar
Glue, Aspartame, flavoring essence spices.
Aforesaid operations step is both needed to be carried out under the protection of inert gas, such as nitrogen, argon gas, helium etc., to prevent from producing
The danger of green powder blast.
Embodiment 5
1) the tailored version clinical nutrition that the present invention is provided is formulated to Mouse Acute Toxicity and chronic toxicity test;
Acute toxicity test in mice:The nutrient powder feeding mice that Bian is prepared with the embodiment of the present invention 1~3, Continuous Observation 14
My god, dead and undue toxicity reaction is had no during experiment, after off-test, put to death mouse, Dissection test mouse, observation liver, kidney,
Spleen, stomach, the heart, lung and intestines, are showed no abnormal change.By standard of acute toxicity, the sample belongs to nontoxic level.
Murine chronic toxicity test:The nutrient powder feeding mice that Bian is prepared with the embodiment of the present invention 1~3, continuously feeds 90
My god, the mouse behavioral activity of nutrient powder prepared by the result of the test feeding embodiment of the present invention 1~3 is normal, and drinking-water of ingesting is normal, body
Weight is normal to be increased, and blood parameters and hematology fluctuate in normal range (NR), and routine urinalysis and marrow index are in normal model
Interior fluctuation is enclosed, internal organs no abnormality seen is organized, generally speaking has no that toxicity reacts, from above-mentioned experiment, prepared by the present invention matches somebody with somebody
Square product is safe and nontoxic.
2) the tailored version clinical nutrition that the present invention is provided is formulated on the anti-infectious influence of mouse burnt degree;
Take the embodiment of the present invention 1~3 preparation nutrient powder tested, while set comparative example 1, comparative example 2, blank group and
Control group, comparative example 1 is adopted using nutrient powder prepared by amino acid and nucleotides, comparative example 2 is deleted in the nutrient formulation of embodiment 2
With the nutrient powder that the preparation of integration of drinking and medicinal herbs composition is deleted in the nutrient formulation of embodiment 2.
Kunming mice 32 is taken, male and female half and half are randomly divided into 2 groups, every group 16.By staphylococcus aureus
(CMCC26112), beta hemolytic streptococcus (CMCC32210) is seeded in beef extract soup fluid nutrient medium, puts 37 DEG C of cultures
Case 18h.It is 10 with normal saline dilution-1~10-8The bacterium solution of concentration.By the staphylococcus aureus of each concentration, hemolytic
Streptococcus, Diplococcus pneumopniae, haemophilus influenzae are according to 0.5ml/ dosage, difference intraperitoneal injection infecting mouse.Observation mouse
Death state in 5d, tests out the minimum lethal dose (MLD) that test strain causes the death of animal 100%.
Minimum lethal dose (MLD) of the experiment bacterial strain of table 1 to mouse
Kunming mice 140 is taken respectively, and male and female half and half are randomly divided into 14 groups, every group 10, carry out the infection of each strain
The dead Protection of induced mice.1~embodiment of embodiment 3,2 groups of 1~comparative example of comparative example are according to dosage 1000mg/kg/
Day gavages, blank group isometric physiological saline gavage, control group 0.4g/kg Amoxicillins gavage.After continuous 3d, each group
In the 4th day, according to minimum lethal dose (MLD) intraperitoneal injection different strains.According to preceding dose, it is further continued for giving each group mouse
Gavage 3d.After observed and recorded infection in 7d each group mouse death toll, calculate the death rate.
Respectively protective effect of the formula to the death of infection of staphylococcus aureus induced mice of table 2
The respectively formula protective effect dead to beta hemolytic streptococcus infection induced mice of table 3
Experiment shows 1~embodiment of embodiment 3,2 groups of 1~comparative example of comparative example to staphylococcus aureus, beta hemolysis
Property streptococcal infection induced mice death has different degrees of protective effect.
3) the tailored version clinical nutrition that the present invention is provided is formulated the influence to mouse burnt degree healing state;
The nutrient powder for taking the preparation of the embodiment of the present invention 1~3 is tested, while setting comparative example 1, comparative example 2, blank
Group, using nutrient powder prepared by amino acid and nucleotides is deleted in the nutrient formulation of embodiment 2, comparative example 2 is using real for comparative example 1
Apply the nutrient powder of deletion integration of drinking and medicinal herbs composition preparation in the nutrient formulation of example 2, blank control group gavage chow diet.
Take kunming mice 140 respectively, male and female half and half are randomly divided into 7 groups, every group 20, to the same portion of each mouse
Position carries out slight burns, and burn surface area is 3 × 3cm, then carries out normal therapeutic to each mouse.Outside normal therapeutic, implement
Example 1~3, the nutrient powder of comparative example 1~2 are persistently taken to wound healing, blank according to dosage 1000mg/kg/day gavages
Control group feeding chow diet is to wound healing.For burned mice, judging the standard of drug effect has the sense of healing time, wound
Dye situation, its experimental result is as shown in table 3.
The experimental result of the wound healing of table 3
As seen from the above table, the integration of drinking and medicinal herbs component and dietary fiber of present invention addition, seek with protein, carbohydrate etc.
Synergy well is there occurs between foster element, it has adjuvant treatment effect to fire victim;In addition, by with comparative example
1 and comparative example 2 be compared discovery, fire victim is anti-infective and wound for improving for amino acid, nucleotides and integration of drinking and medicinal herbs composition
Mouth healing is essential, and it complements each other with other components of the present invention, gives full play to respective effect, could obtain excellent
Effect.
Specific embodiment of the invention has been described in detail above, but it is only used as example, and the present invention is not intended to limit
In particular embodiments described above.To those skilled in the art, any equivalent modifications carried out to the practicality and replace
In generation, is also all among scope of the invention.Therefore, the equalization made without departing from the spirit and scope of the invention is converted and repaiied
Change, all should be contained within the scope of the invention.
Claims (9)
1. a kind of burn tailored version clinical nutrition is formulated, it is characterised in that including following component:Protein and amino acid, nucleosides
Acid, fat, carbohydrate, dietary fiber, macroelement, trace element, vitamin, meals elite, integration of drinking and medicinal herbs composition, day
Right plant compound and new resource food;
Wherein, the amino acid includes Glu, L-arginine, taurine;
Wherein, the integration of drinking and medicinal herbs composition includes peppermint, Poria cocos, pawpaw, dandelion, spina date seed, honeysuckle.
2. a kind of burn tailored version clinical nutrition according to claim 1 is formulated, it is characterised in that also thickened including food
Agent and food additives, the food thickening agent be guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar,
At least one in gelatin, Arabic gum, the food additives be Aspartame, flavoring essence spices, brown sugar at least
It is a kind of.
3. a kind of burn tailored version clinical nutrition according to claim 1 is formulated, it is characterised in that n-6 in the fat
The ratio of aliphatic acid and n-3 aliphatic acid is 4:1~2.
4. a kind of burn tailored version clinical nutrition according to claim 1 is formulated, it is characterised in that the vitamin is water
Soluble vitamin and liposoluble vitamin, the weight of the liposoluble vitamin account for the 10%~40% of vitamin gross weight.
5. a kind of burn tailored version clinical nutrition formula according to claim 1, it is characterised in that the dietary fiber is
Water-soluble dietary fiber.
6. a kind of burn tailored version clinical nutrition according to claim 1 is formulated, it is characterised in that the weight of the component
Number is:Protein and 20~40 parts of amino acid, 0~1 part of nucleotides, 10~20 parts of fat, 30~60 parts of carbohydrate, meals
2~8 parts of fiber of food, 0.6~1.2 part of macroelement, 0.05-0.2 parts of trace element, 0.1~0.3 part of vitamin, meals elite
0.2~0.5 part, 0.2~3 part of integration of drinking and medicinal herbs composition, 0.1-1 parts and new resource food 0.01-0.2 of natural plants compound
Part.
7. a kind of burn tailored version clinical nutrition formula according to claim 6, it is characterised in that the integration of drinking and medicinal herbs into
The parts by weight of each component are as follows in point:0~1 part of peppermint, 0~1 part of Poria cocos, 0~1 part of pawpaw, 0~1 part of dandelion, spina date seed
0~1 part, 0~1 part of honeysuckle.
8. the preparation method that a kind of burn tailored version clinical nutrition as any one of claim 1~7 is formulated, its feature
It is to comprise the following steps:
Step one, by the protein and amino acid of predetermined weight number, nucleotides, fat, carbohydrate, dietary fiber, often
Secondary element, trace element, vitamin, integration of drinking and medicinal herbs composition, natural plants compound and new resource food prepare granulating respectively
Footpath is 150~250 μm of powder;
Step 2, the powder for preparing the step one are poured into cone-type mixer and are well mixed successively;
Step 3, using in the step 2 be well mixed powder be prepared into nutrient powder, nutrition emulsion, capsule, tablet, ball
At least one in agent or oral liquid;
Wherein, the raw material of the integration of drinking and medicinal herbs composition crushed, water extraction concentration, and concentrate carried out into spray drying be made medicine
Eat homologous component powders;
Wherein, the vitamin and fat are processed by microencapsulation be prepared into vitamin powder and fat powder respectively.
9. the preparation method that a kind of burn tailored version clinical nutrition as any one of claim 1~7 is formulated, its feature
It is to comprise the following steps:
Step 1) prepare the protein containing predetermined weight number and amino acid, nucleotides, fat, carbohydrate, meals fibre
The former material of dimension, macroelement, trace element, vitamin, integration of drinking and medicinal herbs composition, natural plants compound and new resource food
Material, according to the physical behavior of raw material, adds successively according to sequencing, is stirred while addition, and raw material is obtained
Mixed emulsion;
Step 2) by step 1) mixed emulsion that obtains carries out emulsifying homogeneous, concentrating sterilizing, obtains concentrate;
Step 3) by step 2) concentrate that obtains is spray-dried, sieved, and is prepared into powder, and above-mentioned powder is prepared into
At least one in nutrient powder, nutrition emulsion, capsule, tablet, pill or oral liquid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710197736.6A CN106858595A (en) | 2017-03-29 | 2017-03-29 | One kind burn tailored version clinical nutrition formula and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710197736.6A CN106858595A (en) | 2017-03-29 | 2017-03-29 | One kind burn tailored version clinical nutrition formula and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106858595A true CN106858595A (en) | 2017-06-20 |
Family
ID=59159614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710197736.6A Pending CN106858595A (en) | 2017-03-29 | 2017-03-29 | One kind burn tailored version clinical nutrition formula and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106858595A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107242550A (en) * | 2017-06-29 | 2017-10-13 | 上海复旦奥医医学科技有限公司 | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof |
CN107319524A (en) * | 2017-06-29 | 2017-11-07 | 上海复旦奥医医学科技有限公司 | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof |
CN107440121A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof |
CN107440102A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof |
CN107616490A (en) * | 2017-08-23 | 2018-01-23 | 上海奥医生物医药科技有限公司 | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof |
CN110038131A (en) * | 2019-04-25 | 2019-07-23 | 河北康睿达脂质有限公司 | It is a kind of burn trauma skin cell repair structured lipid composition and its application |
CN114601172A (en) * | 2022-03-10 | 2022-06-10 | 山东若尧特医食品有限公司 | Formula food of glutamine composition with special medical application and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104286849A (en) * | 2014-09-26 | 2015-01-21 | 上海励成营养产品科技股份有限公司 | Diabetes-specific enteral nutrition multi-polymerization agent |
CN105901703A (en) * | 2016-04-19 | 2016-08-31 | 上海海洋大学 | A marine organism type enteral nutrition preparation used for burn patients |
CN106490605A (en) * | 2016-12-23 | 2017-03-15 | 上海奥医生物医药科技有限公司 | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof |
-
2017
- 2017-03-29 CN CN201710197736.6A patent/CN106858595A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104286849A (en) * | 2014-09-26 | 2015-01-21 | 上海励成营养产品科技股份有限公司 | Diabetes-specific enteral nutrition multi-polymerization agent |
CN105901703A (en) * | 2016-04-19 | 2016-08-31 | 上海海洋大学 | A marine organism type enteral nutrition preparation used for burn patients |
CN106490605A (en) * | 2016-12-23 | 2017-03-15 | 上海奥医生物医药科技有限公司 | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107242550A (en) * | 2017-06-29 | 2017-10-13 | 上海复旦奥医医学科技有限公司 | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof |
CN107319524A (en) * | 2017-06-29 | 2017-11-07 | 上海复旦奥医医学科技有限公司 | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof |
CN107440121A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof |
CN107440102A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof |
CN107616490A (en) * | 2017-08-23 | 2018-01-23 | 上海奥医生物医药科技有限公司 | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof |
CN110038131A (en) * | 2019-04-25 | 2019-07-23 | 河北康睿达脂质有限公司 | It is a kind of burn trauma skin cell repair structured lipid composition and its application |
CN110038131B (en) * | 2019-04-25 | 2021-04-30 | 河北康睿达脂质有限公司 | Structural lipid composition for repairing burn and wound skin cells and application thereof |
CN114601172A (en) * | 2022-03-10 | 2022-06-10 | 山东若尧特医食品有限公司 | Formula food of glutamine composition with special medical application and preparation method thereof |
CN114601172B (en) * | 2022-03-10 | 2024-03-19 | 山东若尧特医食品有限公司 | Formula food with special medical application of glutamine composition and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106858620A (en) | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof | |
CN106858595A (en) | One kind burn tailored version clinical nutrition formula and preparation method thereof | |
CN106962912A (en) | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof | |
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN101822383B (en) | Functionality nutritional meal replacing food suitable for tumor patient and preparation method thereof | |
CN106616615A (en) | Clinical nutrient formula special for tumor and preparation method of clinical nutrient formula | |
CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
CN109123643A (en) | A kind of preparation method of cereal generation meal ball | |
CN106942748A (en) | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof | |
CN101473953A (en) | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application | |
CN107319524A (en) | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof | |
CN107616490A (en) | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof | |
CN108013454A (en) | Gynaecological imflammation tailored version clinical nutrition formula and preparation method thereof | |
CN108719984B (en) | Meal replacement nutrition bar for gout population and preparation method thereof | |
CN107440103A (en) | A kind of respiratory disease tailored version clinical nutrition formula and preparation method thereof | |
CN104605353A (en) | Formula food suitable for being eaten by tumor patients after operation and preparation method of formula food | |
CN106578093A (en) | Wound, infection, operation and other stress state special-purpose clinical nutrition formula and preparation method thereof | |
CN107440102A (en) | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof | |
CN103355544A (en) | Lactation sow forage | |
CN107373672A (en) | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof | |
CN108703365A (en) | Protein allergy tailored version clinical nutrition formula and preparation method thereof | |
CN104222638A (en) | Functional feed for preventing and treating carp branchiomycosis and preparation method of functional feed | |
CN105124276A (en) | Feed for raising crabs | |
CN104304679A (en) | Multivitamin C, E immune polysaccharide microemulsion preparation and preparation method and application of preparation | |
KR102430901B1 (en) | Nutritional snack for companion animals containing dried powder of militaris cordyceps grown using edible insects as a medium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170620 |
|
RJ01 | Rejection of invention patent application after publication |